M3, Inc. (MTHRY)
OTCMKTS · Delayed Price · Currency is USD
6.70
-0.45 (-6.29%)
Nov 6, 2025, 3:58 PM EST
M3, Inc. Market Cap
M3, Inc. has a market cap or net worth of $9.32 billion as of November 7, 2025. Its market cap has increased by 17.07% in one year.
Market Cap
9.32B
Enterprise Value
8.99B
Revenue
2.13B
Ranking
n/a
PE Ratio
32.57
Stock Price
$6.70
Market Cap Chart
Since September 16, 2004, M3, Inc.'s market cap has increased from 488.38M to 9.32B, an increase of 1,807.48%. That is a compound annual growth rate of 14.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 9.27B | 53.54% |
| Dec 30, 2024 | 6.04B | -46.29% |
| Dec 29, 2023 | 11.24B | -38.99% |
| Dec 30, 2022 | 18.42B | -46.06% |
| Dec 30, 2021 | 34.15B | -46.65% |
| Dec 30, 2020 | 64.01B | 210.73% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 659.64M |
| Glass House Brands | 595.49M |
| Northwest Biotherapeutics | 373.25M |
| American Oncology Network | 325.20M |
| Nika Pharmaceuticals | 311.89M |
| CytoDyn | 308.64M |
| Silence Therapeutics | 294.74M |